NICOLE HUGHEY: Open Payments
NPI 1699445866 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 94 payments from 21 companies in 2025. Trend: 2023 $783 · 2024 $801 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $592 |
| GlaxoSmithKline, LLC. | 18 | $285 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $175 |
| Insmed, Inc. | 6 | $112 |
| Viatris Specialty LLC | 5 | $86 |
| United Therapeutics Corporation | 3 | $82 |
| GENZYME CORPORATION | 4 | $80 |
| Merck Sharp & Dohme LLC | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| PFIZER INC. | 3 | $52 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, FASENRA, Arikayce, NUCALA, YUPELRI, Tyvaso, DUPIXENT.
Industry payments across OK — which companies pay providers there.
